Skin Cancer

Sensitivity, specificity, mean accuracy, and AUC improved significantly with neural network input

Results will likely "encourage a practice change," editorialists say

Also in TTHealthWatch: chronic pain in U.S. adults, and a new treatment for C. diff

"One of the highest tumor response rates we've seen in any cancer," study discussant says

Clinical implications apply to virtually all solid tumors and possibly hematologic malignancies

Both sides likely to appeal the ruling

Retifanlimab produced responses in 52% of patients with untreated unresectable disease

Health news and commentary from around the Web gathered by MedPage Today staff

Randomized study finds no benefit with 12 months of nicotinamide versus placebo

Routine physical finds stiffened gait a result of osteoarthritis, but no treatment needed

Health news and commentary from around the Web gathered by MedPage Today staff

Early research on detecting serious side effect of cancer therapy

Encorafenib-binimetinib tops vemurafenib, but checkpoint inhibitors remain first-line choice

Melanoma patients who had vax plus PD-1 inhibitor did better than those on pembrolizumab alone